Familial Ovarian Cancer and Early Ovarian Cancer: Biologic, Pathologic, and Clinical Features
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynaecology,Pathology and Forensic Medicine
Reference121 articles.
1. The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
2. The Contribution of Germline BRCA1 and BRCA2 Mutations to Familial Ovarian Cancer: No Evidence for Other Ovarian Cancer–Susceptibility Genes
3. Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer
4. Unusual case of Smith-Lemli-Opitz syndrome “type II”
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis;Evidence-Based Complementary and Alternative Medicine;2021-11-03
2. Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study;Journal of Cancer;2020
3. Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin;Familial Cancer;2017-07-06
4. Ovarian Cancer Biomarker Discovery Based on Genomic Approaches;Journal of Cancer Prevention;2013-12-30
5. Epidemiology of Epithelial Ovarian Carcinoma;Ovarian Neoplasm Imaging;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3